{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:52:03Z","timestamp":1753876323503,"version":"3.41.2"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"crossref","award":["23K15111"],"award-info":[{"award-number":["23K15111"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Advances in medical treatments have allowed many congenital heart disease patients to reach adulthood, resulting in an increase in adult congenital heart disease (ACHD) cases. Managing heart failure (HF) in ACHD patients is a significant concern, particularly due to limited understanding of optimal pharmacological therapies. Conduit dysfunction and right heart failure are common in the late phase after the Rastelli procedure, but right HF is not well understood, and standard medications for acquired HF are not particularly effective. Consequently, there is a knowledge gap regarding optimal treatment strategies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case summary<\/jats:title>\n                  <jats:p>We report the case of a 19-year-old woman with a history of Blalock\u2013Taussig shunt, Rastelli procedure, and reoperation for conduit stenosis. She was diagnosed with chronic active Epstein\u2013Barr virus infection and admitted due to exertional dyspnoea and orthopnoea. On admission, she exhibited signs of acute HF with severe left ventricular dysfunction and conduit stenosis. Initial management with diuretics was insufficient, requiring inotropic support. Right heart catheterization revealed conduit failure, necessitating surgical replacement. Postoperatively, optimized medical therapy, including beta-blockers, ivabradine, vericiguat, and SGLT-2 inhibitors, was administered. Over several months, her biventricular function improved significantly, and she underwent umbilical cord blood transplantation for EBV infection, with a favourable outcome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>This case highlights the importance of combining surgical and pharmacological strategies in managing complex ACHD with biventricular dysfunction. Identifying underlying causes, such as chronic myocarditis due to EBV infection, is crucial. Ivabradine allowed for beta-blocker increase, and with newer agents like vericiguat and SGLT-2 inhibitors, significantly improved cardiac function.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytaf215","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T07:05:15Z","timestamp":1745823915000},"source":"Crossref","is-referenced-by-count":0,"title":["Biventricular reverse remodelling achieved through combined surgical and optimal medical therapy in an adolescent female post-Rastelli procedure: a case report"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5013-6624","authenticated-orcid":false,"given":"Natsumi","family":"Kashimura","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9355-2418","authenticated-orcid":false,"given":"Tomohiro","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakiko","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Minamino","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine , 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421 ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"2025052601113514900_ytaf215-B1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/eurheartj\/ehaa554","article-title":"2020 ESC guidelines for the management of adult congenital heart disease","volume":"42","author":"Baumgartner","year":"2021","journal-title":"Eur Heart J"},{"key":"2025052601113514900_ytaf215-B2","first-page":"e698","article-title":"2018 AHA\/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Stout","year":"2019","journal-title":"Circulation"},{"key":"2025052601113514900_ytaf215-B3","first-page":"495","article-title":"Effects of beta-blockers for congestive heart failure in pediatric and congenital heart disease patients: a meta-analysis of published studies","volume":"63","author":"Cho","year":"2015","journal-title":"Minerva Cardioangiol"},{"key":"2025052601113514900_ytaf215-B4","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/CIRCULATIONAHA.117.031438","article-title":"Effect of losartan on right ventricular dysfunction: results from the double-blind, randomized REDEFINE trial (right ventricular dysfunction in tetralogy of Fallot: inhibition of the renin-angiotensin-aldosterone system) in adults with repaired tetralogy of Fallot","volume":"137","author":"Bokma","year":"2018","journal-title":"Circulation"},{"key":"2025052601113514900_ytaf215-B5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijcard.2010.09.057","article-title":"Randomised trial of ramipril in repaired tetralogy of Fallot and pulmonary regurgitation: the APPROPRIATE study (Ace inhibitors for Potential PRevention of the deleterious effects of Pulmonary Regurgitation In Adults with repaired TEtralogy of Fallot)","volume":"154","author":"Babu-Narayan","year":"2012","journal-title":"Int J Cardiol"},{"key":"2025052601113514900_ytaf215-B6","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1161\/CIRCIMAGING.113.001483","article-title":"Mechanisms of right ventricular electromechanical dyssynchrony and mechanical inefficiency in children after repair of tetralogy of fallot","volume":"7","author":"Hui","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"2025052601113514900_ytaf215-B7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1253\/circj.CJ-14-0842","article-title":"The speckle tracking imaging for the assessment of cardiac resynchronization therapy (START) study","volume":"79","author":"Maruo","year":"2015","journal-title":"Circ J"},{"key":"2025052601113514900_ytaf215-B8","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.amjcard.2010.12.026","article-title":"Prevalence of left ventricular systolic dysfunction in adults with repaired tetralogy of fallot","volume":"107","author":"Broberg","year":"2011","journal-title":"Am J Cardiol"},{"key":"2025052601113514900_ytaf215-B9","doi-asserted-by":"crossref","first-page":"e009618","DOI":"10.1161\/JAHA.118.009618","article-title":"Determinants of left ventricular dysfunction and remodeling in patients with corrected tetralogy of Fallot","volume":"8","author":"Andrade","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2025052601113514900_ytaf215-B10","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.jcmg.2024.06.009","article-title":"Multiparametric cardiac magnetic resonance imaging to discriminate endomyocardial biopsy-proven chronic myocarditis from healed myocarditis","volume":"17","author":"Brendel","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025052601113514900_ytaf215-B11","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/bjh.19652","article-title":"l-asparaginase monotherapy as an encouraging approach towards acute fulminant chronic active Epstein-Barr virus infection","volume":"205","author":"Furukawa","year":"2024","journal-title":"Br J Haematol"},{"key":"2025052601113514900_ytaf215-B12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00392-014-0709-z","article-title":"Diagnostic and prognostic validity of different biomarkers in patients with suspected myocarditis","volume":"103","author":"Ukena","year":"2014","journal-title":"Clin Res Cardiol"},{"key":"2025052601113514900_ytaf215-B13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ehjcvp\/pvy011","article-title":"Heart rate, beta-blocker use, and outcomes of heart failure with reduced ejection fraction","volume":"5","author":"Ibrahim","year":"2019","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2025052601113514900_ytaf215-B14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cardfail.2021.07.026","article-title":"Right ventricular ejection fraction and beta-blocker effect in heart failure with reduced ejection fraction","volume":"28","author":"Lam","year":"2022","journal-title":"J Card Fail"},{"key":"2025052601113514900_ytaf215-B15","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.hlc.2023.09.005","article-title":"A systematic review and meta-analysis of randomised controlled trials assessing clinical and haemodynamic outcomes of ivabradine in heart failure with reduced ejection fraction patients","volume":"33","author":"Waranugraha","year":"2024","journal-title":"Heart Lung Circ"},{"key":"2025052601113514900_ytaf215-B16","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.clinthera.2020.10.005","article-title":"Effects of ivabradine on cardiac remodeling in patients with stable symptomatic heart failure: a systematic review and meta-analysis","volume":"42","author":"Wan","year":"2020","journal-title":"Clin Ther"},{"key":"2025052601113514900_ytaf215-B17","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1161\/01.CIR.0000118464.48959.1C","article-title":"Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure","volume":"109","author":"Mulder","year":"2004","journal-title":"Circulation"},{"key":"2025052601113514900_ytaf215-B18","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/ejhf.2486","article-title":"The association of improvement in left ventricular ejection fraction with outcomes in patients with heart failure with reduced ejection fraction: data from CHAMP-HF","volume":"24","author":"DeVore","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2025052601113514900_ytaf215-B19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4250\/jcvi.2020.0025","article-title":"Changes in QRS duration are associated with a therapeutic response to Sacubitril-valsartan in heart failure with reduced ejection fraction","volume":"28","author":"Kim","year":"2020","journal-title":"J Cardiovasc Imaging"},{"key":"2025052601113514900_ytaf215-B20","doi-asserted-by":"crossref","first-page":"ytae512","DOI":"10.1093\/ehjcr\/ytae512","article-title":"Reversible complete left bundle branch block and a wide QRS complex following administration of sodium-glucose cotransporter-2 inhibitor and volume reduction in a patient with systolic heart failure: a case report","volume":"8","author":"Takenaka","year":"2024","journal-title":"Eur Heart J Case Rep"},{"key":"2025052601113514900_ytaf215-B21","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/ejhf.2836","article-title":"Effect of vericiguat on left ventricular structure and function in patients with heart failure with reduced ejection fraction: the VICTORIA echocardiographic substudy","volume":"25","author":"Pieske","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2025052601113514900_ytaf215-B22","doi-asserted-by":"crossref","first-page":"132441","DOI":"10.1016\/j.ijcard.2024.132441","article-title":"Effectiveness of Vericiguat on right ventricle to pulmonary artery uncoupling associated with heart failure with reduced ejection fraction","volume":"415","author":"Hashimoto","year":"2024","journal-title":"Int J Cardiol"},{"key":"2025052601113514900_ytaf215-B23","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s12265-023-10389-3","article-title":"Left ventricular systolic function after 3 months of SGLT2 inhibitor therapy in heart failure patients with reduced ejection fraction","volume":"16","author":"Mustapic","year":"2023","journal-title":"J Cardiovasc Transl Res"},{"key":"2025052601113514900_ytaf215-B24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(18)32484-X","article-title":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial","volume":"393","author":"Halliday","year":"2019","journal-title":"Lancet"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytaf215\/63017608\/ytaf215.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/9\/5\/ytaf215\/63017608\/ytaf215.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/9\/5\/ytaf215\/63017608\/ytaf215.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T05:11:48Z","timestamp":1748236308000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytaf215\/8120784"}},"subtitle":[],"editor":[{"given":"Flemming Javier","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Nabil","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Andrea","family":"Freixa-Benavente","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Karelas","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytaf215","relation":{},"ISSN":["2514-2119"],"issn-type":[{"type":"electronic","value":"2514-2119"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,4,28]]},"article-number":"ytaf215"}}